Miami, Florida, USA
Translating cell and gene therapies (CGTs) from bench to bedside requires a deep understanding of complex biological systems, the ever-shifting regulatory path, and innovative trial design. The cell and gene therapy talks about the regulatory cooperation, patient recruitment, and evidence generation, bridging pre-approval and post-marketing phases.